Health Care Innovation

The Centers for Medicare & Medicaid Services issued an update to the home health payment system on June 22nd. This proposed rule, rife with legalese and sheer complexity, should be held up as Exhibit A for why socialized healthcare schemes such as Medicare for All will never work.   The proposal’s obsessions with “aggregate ...

There is much to like about the Republican legislative agenda released late last week by House Minority Leader Kevin McCarthy, particularly on health policy.   Known as the “Commitment to America,” the plan promises to foster a healthcare system that delivers high-quality personalized care, to invest in breakthrough medicines, and to drive down prices ...

With the midterm elections approaching fast, House Republicans just released their “Commitment to America“—a list of policies they’ll pursue if they win a majority.   Even if the GOP comes out on top in November, these policies are likely a few years away from becoming law, since Democrats will retain ...

President Joe Biden recently relaunched his Cancer Moonshot initiative. His passion for ending cancer is commendable. Unfortunately, the policies he has enacted will undermine his quest.   The Cancer Moonshot aims to reduce the death rate from cancer by 50 percent over the next 25 years by pouring money into cancer research and improving coordination ...

Speaking in Boston earlier this month, President Biden insisted that the United States can “end cancer as we know it and even cure cancers once and for all.”   His “Cancer Moonshot” aims to do just that. Among its many lofty goals, it seeks to halve cancer deaths in the next 25 years. ...

New life expectancy data from the Centers for Disease Control and Prevention seems to indicate that things are getting only worse. Between 2020 and 2021, American life expectancy decreased 0.9 years. That follows a drop of 1.8 years in 2020.

Too often, regulations undermine the competitive process in the name of promoting competition. The ill-conceived Right to Repair legislation exemplify the problems and risks. Under the pretense of promoting competition, states as diverse as Texas and California, Arkansas and Hawaii have all considered bills that would violate medical device companies’ intellectual property rights. While many have been defeated, ...

Listen to Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss his recent 340B hospital study on AM 1590, KWBG Radio in Boone, IA. https://www.pacificresearch.org/wp-content/uploads/2022/02/Wayne-Winegarden-PRI-340B-Study-012522.mp3